Fjarde Ap Fonden Regeneron Pharmaceuticals, Inc. Transaction History

Fjarde Ap Fonden

$11.6 Billion
Q3 2025

A detailed history of Fjarde Ap Fonden transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 35,252 shares of REGN stock, worth $23.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

35,252

Previous 39,452 10.65%

Holding current value

$23.1 Million

Previous $20.7 Million 4.3%

% of portfolio

0.17%

Previous 0.19%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	SELL	$534.91 - $598.71 $2.25 Million - $2.51 Million	-4,200 Reduced 10.65%	35,252 $19.8 Million
Q2 2025 Aug 01, 2025	BUY	$483.07 - $625.6 $3 Million - $3.88 Million	6,200 Added 18.65%	39,452 $20.7 Million
Q1 2025 May 13, 2025	BUY	$634.14 - $744.83 $1.65 Million - $1.94 Million	2,600 Added 8.48%	33,252 $21.1 Million
Q4 2024 Feb 04, 2025	SELL	$701.85 - $1046.91 $210,555 - $314,073	-300 Reduced 0.97%	30,652 $21.8 Million
Q3 2024 Nov 08, 2024	BUY	$1024.09 - $1201.76 $4.61 Million - $5.41 Million	4,500 Added 17.01%	30,952 $32.5 Million
Q1 2024 Apr 25, 2024	BUY	$902.69 - $993.35 $270,807 - $298,005	300 Added 1.15%	26,452 $25.5 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $542,626 - $617,190	-700 Reduced 2.61%	26,152 $23 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $484,715 - $591,059	-700 Reduced 2.54%	26,852 $22.1 Million
Q2 2023 Aug 02, 2023	SELL	$700.03 - $830.35 $210,009 - $249,105	-300 Reduced 1.08%	27,552 $19.8 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $476,343 - $578,879	-700 Reduced 2.45%	27,852 $22.9 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $6.42 Million - $6.97 Million	-9,090 Reduced 24.15%	28,552 $20.6 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $5.54 Million - $7.46 Million	10,100 Added 36.67%	37,642 $22.3 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $104,146 - $122,225	-175 Reduced 0.63%	27,542 $19.2 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $945,111 - $1.17 Million	-1,739 Reduced 5.9%	27,717 $17.5 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $172,209 - $204,288	-300 Reduced 1.01%	29,456 $17.8 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $709,200 - $837,810	-1,500 Reduced 4.8%	29,756 $16.6 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $312,711 - $383,740	700 Added 2.29%	31,256 $14.8 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $95,660 - $121,596	-200 Reduced 0.65%	30,556 $14.8 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $980,550 - $1.18 Million	1,800 Added 6.22%	30,756 $17.2 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $3.32 Million - $4.33 Million	6,720 Added 30.22%	28,956 $18.1 Million
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $369,798 - $543,873	1,100 Added 5.2%	22,236 $10.9 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $1.34 Million - $1.84 Million	4,900 Added 30.18%	21,136 $7.94 Million
Q3 2019 Oct 31, 2019	BUY	$273.46 - $318.39 $300,806 - $350,229	1,100 Added 7.27%	16,236 $4.5 Million
Q2 2019 Jul 17, 2019	SELL	$299.6 - $414.82 $1.71 Million - $2.36 Million	-5,700 Reduced 27.36%	15,136 $4.74 Million
Q1 2019 Apr 29, 2019	BUY	$372.08 - $439.57 $1.31 Million - $1.55 Million	3,517 Added 20.31%	20,836 $8.56 Million
Q4 2018 Jan 31, 2019	SELL	$335.82 - $403.04 $1.24 Million - $1.49 Million	-3,700 Reduced 17.6%	17,319 $6.47 Million
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $386,254 - $449,361	-1,100 Reduced 4.97%	21,019 $8.49 Million
Q2 2018 Jul 12, 2018	BUY	$284.6 - $344.99 $51,797 - $62,788	182 Added 0.83%	22,119 $7.63 Million
Q1 2018 May 07, 2018	BUY	$315.82 - $393.78 $82,429 - $102,776	261 Added 1.2%	21,937 $7.55 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $1.18 Million - $1.55 Million	3,299 Added 17.95%	21,676 $8.15 Million
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $138,904 - $162,288	322 Added 1.78%	18,377 $8.22 Million
Q2 2017 Aug 08, 2017	BUY	N/A	18,055	18,055 $8.87 Million

Others Institutions Holding REGN

# of Institutions

1,437

Shares Held

88.9M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $70.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account